Stock report · Delisted · Nasdaq
Organovo Holdings Inc (ONVO)
1.87USD Delisted Final close · Apr 24, 2025
ONVO no longer trades. Organovo Holdings was delisted from the Nasdaq in April 2025.
All prices on this page are historical. The last trade was on April 24, 2025, at $1.87.
ONVO stock price history
Final trading statistics
- Final close
- $1.87
- Final trading day
- Apr 24, 2025
- Market cap at delisting
- $3.37M
- Shares outstanding
- 1.80M
- Final 52-week range
- $0.25 – $4.15
- Avg. volume (final 3 mo.)
- 7,596,390
- All-time high
- $3060.00 · Nov 2013
- All-time low
- $1.66 · Apr 2025
- Return since IPO
- -99.5%
- Beta
- 1.13
- Book value / share
- $0.26
- Price / book
- 7.33
About Organovo Holdings Inc
VivoSim Labs, known as Organovo Holdings until April 2025, was a biotechnology company building 3D tissues that model key features of human disease. Its platform used its own NovoGen Bioprinters, automated machines that build living 3D tissue from mammalian cells, along with methods for making bio-inks and printing complex multicellular tissue.
Its lead drug candidate, FXR314, was in a Phase 2/3 trial for inflammatory bowel disease with a focus on ulcerative colitis, and had finished a Phase 1 trial in liver fibrosis with a focus on steatohepatitis. It had research ties with Yale School of Medicine, the Knight Cancer Institute at Oregon Health & Science University, and the University of Virginia.
The company was incorporated in 2007 and based in San Diego, California. Its shares, listed as Organovo Holdings, were delisted from the Nasdaq in April 2025, with the final trade on April 24, 2025 at $1.87.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- San Diego, CA
- Employees
- 14
- IPO date
- February 14, 2012
- Delisted
- April 24, 2025
- SEC CIK
- 1497253
Organovo financials before the delisting
The last 5 fiscal years Organovo reported as a public company, fiscal year ending March.
ONVO revenue and net income
ONVO earnings per share
ONVO annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $109.0K | −$14.7M | −$2.01 |
| FY2023 | $370.0K | −$17.3M | −$1.98 |
| FY2022 | $1.50M | −$11.4M | −$1.31 |
| FY2021 | $0.00 | −$16.8M | −$2.47 |
| FY2020 | $2.20M | −$18.7M | −$3.02 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Organovo stock FAQ
What happened to Organovo stock?
Organovo Holdings was delisted from the Nasdaq in April 2025. The final close was $1.87 on April 24, 2025.
Can I still buy ONVO stock?
No. ONVO is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on April 24, 2025.
What was the last price of ONVO?
ONVO last closed at $1.87 on April 24, 2025, which valued the company at about $3.37M.
How did Organovo do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, Organovo reported revenue of $109.0K and net income of −$14.7M.
When did Organovo go public?
Organovo shares started trading on February 14, 2012.
ONVO no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.